RespireRx Pharmaceuticals Inc (fka RSPI)

[moosedogger]

>>Cortex to Hold Conference Call on October 26 Following Release of CX717 from FDA Clinical Hold
Business Wire - October 24, 2006 10:10 AM ET




Cortex Pharmaceuticals, Inc. (AMEX:COR) received the formal letter from the U.S. Food and Drug Administration on Monday, October 23, 2006 regarding the lifting of the clinical hold on Cortex's lead product candidate, AMPAKINE(R) CX717. The Company will host a conference call at 4:00 p.m. ET (1:00 p.m. PT) on Thursday, October 26th to review the steps it is taking to advance the development of CX717.

Those who wish to participate may do so by dialing 1-877-407-0782 in the United States and 201-689-8567 for international participants. A replay will be available for 45 days after the call and can be accessed by dialing 1-877-660-6853 for participants in the United States and 1-201-612-7415 for international participants and entering account number 286 and conference ID 218465 when prompted. <<